scholarly journals Immediate Administration of Zoledronic Acid Reduces Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women With Early Breast Cancer: 12-Month Analysis of the E-ZO-FAST Trial

2012 ◽  
Vol 12 (1) ◽  
pp. 40-48 ◽  
Author(s):  
Antonio Llombart ◽  
Antonio Frassoldati ◽  
Outi Paija ◽  
Harm Peter Sleeboom ◽  
Guy Jerusalem ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Zoledronic Acid ◽  
Bone Loss ◽  
Aromatase Inhibitor ◽  
Postmenopausal Women ◽  
Early Breast Cancer

Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole

Cancer ◽  
2008 ◽  
Vol 112 (5) ◽  
pp. 1001-1010 ◽  
Author(s):  
Nigel J. Bundred ◽  
Ian D. Campbell ◽  
Neville Davidson ◽  
Richard H. DeBoer ◽  
Holger Eidtmann ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Zoledronic Acid ◽  
Bone Loss ◽  
Aromatase Inhibitor ◽  
Postmenopausal Women ◽  
Early Breast Cancer ◽  
Effective Inhibition
Sign in / Sign up

Export Citation Format

Share Document